Lyell Immunopharma Expansion is Underway in Bothell

Cellular therapy company Lyell Immunopharma is investing $50 million in a new 70,000 square foot manufacturing facility located in Bothell, Washington. This investment will support multiple clinical programs and eventual scale-up of manufacturing to meet late stage clinical development needs.

PHOTO: Stephen Hill, Lyell Immunopharma’s Chief Technical Operations Officer (courtesy Lyell Immunopharma)

READ THE STORY at Economic Alliance Snohomish County »